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Abstract
Background: Attention-deficit/hyperactivity disorder (ADHD) is a common neuro-psychiatric problem, affecting 7-
9% of children. Pharmacological interventions are widely used with behavioral treatments in ADHD. Still, the origin
of ADHD is unclear, limiting pharmacological effectiveness and making adverse effects common. The use of
complementary and alternative medicine (CAM) has increased, especially for developmental and behavioral
disorders, such as ADHD. CAM is used by 60-65% of parents of children with ADHD to relieve ADHD-associated
symptoms and to avoid the side effects of conventional medication. Acupuncture has been widely used to treat
patients with ADHD, but the available evidence of its effectiveness is insufficient. Our aim was to evaluate the
effectiveness and safety of acupuncture in patients (both and each treatment naive and conventional therapy
children) with ADHD (any subtype) compared to the waitlist control.
Methods/Design: This study is a waitlist controlled open trial. We used a computer generated randomization
scheme. This randomised, controlled trial had two parallel arms (acupuncture, and waitlist group). Each arm
consisted of 40 participants. The acupuncture group received acupuncture treatment two times per week for a
total of 12 sessions over 6 weeks. Post-treatment follow-up was performed 3 weeks later to complement the 12
acupuncture sessions. Participants in the waitlist group did not receive acupuncture treatments during the first six
weeks but were only required to be assessed. After 6 weeks, the same treatments given to the acupuncture group
were provided to the waitlist group. The primary outcome of this trial included differences in Korean version of
ADHD-Rating Scale (K-ADHD-RS) before randomization, 3 weeks and 6 weeks after randomization, and 3 weeks
after completing the treatment.
Discussion: Subjective measurements, like K-ADHD-RS, are commonly used in ADHD. Although these
measurements have adequate reliability and validity, lack of objective assessment in ADHD may lead to some
disputes, like parental placebo effects. More objective measurements, like Computerized Neurocognitive function
Test (CNT) in this study, are needed in ADHD trials. Furthermore, this trial will provide evidence for the
effectiveness of acupuncture as a treatment for ADHD.
Trial Registration: Clinical Research Information Service (CRiS) KCT0000019
Background
Attention-deficit/hyperactivity disorder (ADHD) is a
common problem, affecting 7-9% of children. The defin-
ing features of ADHD are inattention, hyperactivity, and
impulsivity [1]. There is an abundance of literature dedi-
cated to research for the treatment of ADHD) [2-6].
Most of these research have focused on pharmacological
therapies with less emphasis on psychotherapy and psy-
chosocial interventions [7-9] and even less in the area of
complementary and alternative medicine (CAM) [10,11].
However, the origin of ADHD is unclear, which limits
pharmacological effectiveness and makes adverse effects
common.
The widespread use of stimulant medications for
ADHD, such as methylphenidate (MPD) and dex-amphe-
tamine, is thought to enhance short-term behavioral,
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academic, and social functioning [12]. However, concern
about side-effects, such as tics, insomnia, and irritability,
as well as questions about the long-term safety of these
medicines and personal preference to avoid stimulants,
has led many parents to seek alternative treatments for
ADHD [13-15].
The use of CAM therapies has increased, especially for
developmental and behavioral disorders such as ADHD
[10,13,16-18]. Data from family practice physicians and
internists show that acupuncture is one the most fre-
quently recommended CAM therapies [19,20]. Approxi-
mately 60-65% of parents with children diagnosed with
ADHD have used CAM therapies [10,16,17,21,22]. Acu-
puncture is a relatively simple, inexpensive, and safe
treatment compared to other conventional interventions.
Acupuncture has been widely used to lessen the severity
of the core symptoms in patients with ADHD [23,24].
As a therapeutic intervention, acupuncture is also
increasingly practiced in some Western countries
[25,26]. However, existing evidence may not be rigorous
enough for acupuncture to be recommended for routine
use.
Acupuncture can change brain activity [27-35]. A
brain hemodynamic study conducted in Japan reported
that acupuncture significantly decreased activity in the
dorsomedial prefrontal cortex (DMPFC) [29]. Hyperac-
tivity in the DMPFC is associated with various psychia-
tric diseases with socio-emotional disturbances such as
schizophrenia and ADHD. A fluorodeoxyglucose posi-
tron emission tomography combined computed tomo-
graphy (FDG-PET/CT) study in Korea reported changes
in brain glucose metabolism in specific brain areas fol-
lowing stimulation by acupuncture [32]. Collectively,
these findings suggest that acupuncture might be effec-
tive to treat ADHD.
There are a large number of studies of the clinical effi-
cacy of acupuncture in ADHD published globally, espe-
cially in China, but not all demonstrate a beneficial
effect on ADHD [13,23,24,36].
Objectives
The present study aimed to evaluate the effectiveness of
acupuncture in patients with ADHD (any subtype) com-
pared to waitlist control and to evaluate the safety of
acupuncture in patients with ADHD (any subtype).
Methods/Design
Design
A 6-week, randomised, waitlist controlled trial of acupunc-
ture for the treatment of ADHD in children/adolescents is
being conducted at Kyung-Hee Oriental Medical center,
Seoul, Korea. All screening appointments and study visits
occur in the neuropsychiatry clinic for outpatients. This
study was ethically approved by the Kyung-Hee Korean
Medical Center Institutional Review Board, and was regis-
tered with the Clinical Research Information Service
(CRiS) (KCT0000019) as a waitlist controlled, randomised
clinical trial. This study had two parallel arms (acupunc-
ture and waitlist group) with a 1:1 patient allocation ratio
(40 participants per arm).
Care providers
The providers went through 6 years of regular Korean
medical college education and each was licensed a Korean
Medical Doctor (KMD) degree. All the KMDs have under-
gone acupuncture safety education. These practitioners
were chosen on the basis of their expertise in the field,
their certified status and agreement to abide by the study
protocols. Every practitioner is an apprentice doctor of
“Department of Neuropsychiatry, College of Korean medi-
cine, Kyung-Hee University” during this trial period.
Participants
Parents were initially screened by phone, and their chil-
dren were included in the study if the inclusion criteria
were met. The inclusion criteria includes being between 7-
18 years of age, having a diagnosis of ADHD (any subtype)
according to Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) criteria and having an informed ver-
bal and written consent from parents and participants. It
did not matter whichever intervention (pharmacological,
psychosocial therapy, educational, or occupational therapy,
as examples) was used, if there were not any change of
ADHD treatments/symptoms for the past 2 weeks. Exclu-
sion criteria are a diagnosis of a developmental disorder,
past history of epilepsy, the presence of another neurotic
disorder, pregnancy, and any changes in medications dur-
ing the course of the study. During waitlist period, a CGI-I
score ≥6, is a cue for the participant to stop waiting and to
drop-out.
Measures
DSM-IV ADHD diagnostic criteria [1,37] were used by
the principal investigator to establish a diagnosis. Once
randomised, participants were evaluated by the principal
investigator during study visits at baseline and weeks 3
and 6 (or 3, 6, 9, and 12). The reliable and validated
Korean version of the ADHD rating scale (K-ADHD-RS)
[38] was used pre- and post-intervention as a primary
outcome measure.
Primary outcome measures
The primary outcomes for the study were changes in
ADHD symptoms from baseline to week 6 (or from week
6-12) as measured by the K-ADHD-RS [38]. The K-
ADHD-RS is an 18-item standardized, valid, reliable
instrument for the diagnosis and also a weekly assess-
ment tool for checking the of treatment response among
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children and adolescents with ADHD [39]. Each item on
the instrument describes one of the symptoms of ADHD
rated on a 0-3 point Likert scale (0 = never or rarely, 1 =
sometimes, 2 = often, and 3 = very often) [39]. The prin-
cipal investigator administered the K-ADHD-RS to the
parent at each study visit. Nationally representative
norms are available for the scale and were used to deter-
mine eligibility [39].
Secondary outcomes
The Clinical Global Impression (CGI) rating scale is also
a commonly used measure of symptom severity, treat-
ment response, and the efficacy of treatments in treat-
ment studies of patients with mental disorders [40]. The
Clinical Global Impression severity scale (CGI-S) was
used at week 3 and 6 (or weeks 3, 6, 9, and 12). CGI-S
requires the clinician to rate the severity of the patient’s
illness at the time of assessment, relative to the clini-
cian’s past experience with patients who have the same
diagnosis. Considering total clinical experience, a patient
is assessed on the severity of mental illness at the time
of rating on a 1-7 scale (1 = normal or not at all ill, 2 =
borderline mentally ill, 3 = mildly ill, 4 = moderately ill,
5 = markedly ill, 6 = severely ill, and 7 = extremely ill)
[41]. The Clinical Global Impression improvement scale
(CGI-I) is used at week 3 and 6 (or weeks 3, 6, 9, and
12) to rate the worsening, maintenance, or improvement
in global impairment of participants enrolled in the
study compared with baseline [41]. The CGI improve-
ment scale includes an eight-point scale for scoring (0 =
not assessed, 1 = very much improved, 2 = much
improved, 3 = minimally improved, 4 = no change, 5 =
minimally worse, 6 = much worse, and 7 = very much
worse) [41].
The Korean version of Child Behavior Checklist (K-
CBCL) was used at week 3 and 6 (or weeks 3, 6, 9, and
12). CBCL has been proposed as a non-ideological mea-
sure to characterize comorbidity in individuals with
ADHD [42,43]. The CBCL is an empirically derived,
highly valid and reliable parent checklist of pediatric psy-
chopathology that is composed of several dimensions and
scored according to established algorithms [44]. As a par-
ent-completed measure, the CBCL provides a common
metric across patients and studies that is free from clini-
cian interpretation [45]. Subsequent reports have proven
the utility of this approach [46-50].
The Frankfurt Attention Inventory (FAIR) [51] mea-
suring concentration behavior consists of 640 stimuli
with high similarity that have to be discriminated
against each other within 6 min. The FAIR test quanti-
fies aspects of concentration behavior displayed in four
test scores: marker value (MV) expresses comprehension
of test instructions, performance value (PV) informs on
the amount of attentively processed test items during a
defined test period, quality value (QV) depicts the
amount of attentively made decisions respective to the
total amount of decisions, and the continuity value (CV)
reflects the extent of continuously upheld concentration
over the entire test duration. The FAIR task provides
good test-retest reliability expressed as a Crohnbachs’
alpha between 0.85 and 0.91 [51].
The Computerized Neurocognitive function Test
(CNT) is used at week 3 and 6 (or week 3, 6, and 12).
CNT is extremely sensitive to virtually all of the clinical
conditions associated with cognitive dysfunction. It is
capable of calculating reaction times with millisecond
accuracy, and can generate massive amounts of precise
data. In this study, CNT40© (Maxmedica; http://www.
maxmedica.co.kr, Seoul, Korea)[52] is selected to make
cognitive evaluations of attention and memory function.
CNT40 consists of 18-items: Digit Span Test, Visual
Span Test, Auditory CPT, Auditory Controlled CPT,
Visual CPT, Visual Controlled CPT, Crossover Test,
Modality Shift Test, Word-Color Test, Trial Making
Test, Card Sorting Test, Verbal Learning Test, Visual
Learning Test, Hypothesis Formation Test, Finger Tap-
ping Test, Raven’s CPM, Raven’s SPM and Color Trail
Making Test. Among these items, the Digit Span Test,
Visual Span Test, Auditory CPT, Visual CPT and Verbal
Learning Test are used to assess attention and memory
dysfunction in ADHD patients.
Korean version of Conners’ parent Rating scale: short
version (K-CPRS) [53,54] and Korean version of IOWA-
Conners Rating scale: short version (K-IOWA) [55],
which use observer ratings, are included to help assess
ADHD and evaluate problem behavior in children and
adolescents.
Randomization and treatment allocation
This study is designed as a waitlist controlled open trial.
Eligible participants were randomly allocated to one of
two groups: group A (acupuncture) and group W (wait-
list). In each group, participants were stratified accord-
ing to the pharmacologic intervention at the initiation
of the study. A computer generated randomization
scheme was used. The principal investigator generated
the random allocation sequences without any notice to
sub-investigators. Stratified randomization was per-
formed as a separate randomization procedure within
each of two subsets of participants (without pharmaco-
logic intervention, 1-60; with pharmacologic interven-
tion, D1-D40. Other treatments were not concerned.) by
using block size “4”. Each number and its randomised
letter (A or W) were placed in an opaque envelope.
Each envelope was numbered consecutively from 1-60
and D1-D40. As each parent called to have their child
screened, they were allocated the next consecutive num-
ber once they were eligible, so that for each eligible
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participant, no. 1 was allocated to envelope no. 1, etc.
The screener was unaware of the sequence of group
allocation at the time of screening phase. Hence, alloca-
tion was concealed at the time of recruiting.
Sample size justification
Sample size calculations are performed to determine the
number of participants needed to detect effect sizes
similar to those that have been reported in recent
ADHD medication trials [56]. This study is powered to
detect a 7.04 difference between the groups. A sample
size of 32 per group is required to achieve 80% power
with a 2-tailed significance level of .05, assuming an
equivalent standard deviation of 9.9 in both groups. Esti-
mating a 20% dropout during the study, a minimum of
80 total participants are needed to reach the target 32
participants per group [nc =
2(Zα + Zβ)2σ 2
(μc − μt)2
, μc - μt:
Mean difference = 7.04, s2 = Assumed Common Var-
iance of both treatment and control group (Standard
Deviation = 9.9), n = 32]
Recruitment and withdrawals
Recruitment for the study commenced in July 2010 and
the first participant was enrolled in July 2010. Participant
recruitment is ongoing. Each participant is qualified and
enrolled into the study separately, and has their own start
date. The study end-point goal is December 2011. Paid
advertisements were placed in free-newspapers with
metropolitan-wide circulations. Paid advertising bills were
also inserted between the pages of the morning newspa-
per. Websites advertisements were placed on several blogs
for free, including http://www.ebombit.com and happiend.
tistory.com. Short, text-only advertisements were also
placed on several ADHD parents’ internet community
sites for free. As part of the informed consent forms, the
parents of the participants were advised that they were
free to withdraw their child/children from the study at any
stage without any consequences.
Protocol
Group A (acupuncture group) continued with their
existing program and the acupuncture protocol was
added to their regimen. Group W (waitlist group) con-
tinued with their existing program and the waitlist pro-
tocol was added to their regimen. The participants in
group A attended a clinical facility for the first 6 weeks
and received 12 treatments (two times per week) for
approximately 20 minutes. During this first 6-week per-
iod, group W consisted of children who continued with
their existing ADHD treatment regimen as prescribed
by their pediatrician, clinical psychologist and/or medi-
cal doctor. Then, the participants in group W were
scheduled for another 12 treatments over the next 6
weeks (same as group A, two times per week).
Acupuncture protocol
Definition of acupuncture
Acupuncture originated in ancient East Asia approxi-
mately 2,500 years ago and is a key component of tradi-
tional Korean medicine or traditional Chinese medicine.
Acupuncture techniques involve insertion of needles
and the stimulation of the needles may involve manual,
electrical, heat, laser or other forms of stimulation [57].
Acupuncture protocol
For every treatment visit, participants are treated with 13
acupuncture points [Baihui (GV20)*1, Sishencong (EX-
HN1)*4, Hegu (LI4)*2, Quchi (LI11)*2, Sanyinjiao (SP6)*2,
Taichong (LR3)*2] (Table 1) [58]. Points are first sterilized
with alcohol, and then thin, disposable acupunctures are
inserted to a depth of approximately 0.3-0.5 B-cun (head:
0.3 B-cun; arms and legs: 0.5 B-cun) until a characteristic
de qi is felt by the patient without manual stimulation.
Acupunctures are maintained for 20 minutes in a supine
position. Stainless steel acupunctures (0.20 mm in dia-
meter and 30 mm long; DONGBANG Acupuncture;
http://www.dbneedle.com; Seoul, Korea) are used. This
treatment is conducted two times per week for 6 weeks.
There are no co-interventions without a life-style educa-
tion for their parents. An education for parents is con-
ducted during visits in weeks 3 and 6.
Waiting list protocol
The control group will be in the 6 weeks waiting list
without getting additional ADHD treatment. In the first
visit at week 3 and at week 6, a life-style education for
parents will be conducted with an ADHD symptom
improvement check. A CGI-I score ≥6, is a cue for the
participant to stop waiting and drop-out (then, the same
as in the acupuncture treatment group for study ethical
issues). After the waiting endpoint, participants will
similarly be given acupuncture treatment for 6 weeks
without an additional life-style education for parents.
Risks
One of the advantages of acupuncture is that the inci-
dence of adverse effects is substantially lower than that
of many drugs used for the same conditions [59]. In a
review by Ernst [60], the most common reported
adverse effects were pain (1-45%), fatigue (2-41%), and
bleeding (0.03-38%). Although these are rare [61,62],
acupuncture is associated with life-threatening compli-
cations that include pneumothorax, angina pectoris, sep-
tic sacroilitis, epidural abscess, and temporomandibular
abscess [63]. For an accurate observation of acupuncture
adverse effects, we made an “Adverse Events Report” at
every visit.
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Ethics review and informed consent
The trial protocol was reviewed by the Kyung-Hee Korean
Medical Center Institutional Review Board. We prepared
two types of consent forms, one for participants who are
7-13-years-of-age (explained in easier words) and another
for those who are 14-18-years-of-age. For 7-13-year-old
participants, a “comprehension check form” is used to
confirm their full understanding. All children participants
make their own decisions about participation in a clinical
trial. All parents of the participants are issued with dupli-
cate copies of the informed consent forms, with the origi-
nal copies kept by the hospital. The informed consent
form conveys the following information: names of the
chief investigator and supervisors; the name of the hospital
and the department conducting the research, a brief
description of the control and treatment groups, the dura-
tion of the study, the questionnaires used, the Ethics
approval, the right to withdraw their child at any time, and
the fact that the results of the study will be disseminated
via conferences and publications while maintaining the
child’s privacy.
Analysis
Tests of potential differences across study groups on
demographic and clinical history variables were per-
formed by means of analysis of covariance (ANCOVA)
for continuous measures and Pearson c2 for categorical
variables. Every analysis conducted using the SPSS soft-
ware (SPSS 12.0KO for Windows©), and performed
among two randomised (acupuncture, and waitlist)
groups and their stratified (treatment naive, and conven-
tional therapy) sub-groups. The primary analysis will
compare outcomes for each primary and secondary out-
come measure among the groups to estimate treatment
effect with 95% confidence interval (CI). An intention-
to-treat (ITT) analysis will be undertaken of the 3-week
and 6-week (respectively 9-week and 12-week) data
from the K-ADHD-RS, due to some participants who
commence the study but do not complete.
Discussion
We have a presented the design and the protocol for the
randomised controlled trial of acupuncture for child-
hood ADHD. The participants of this study will have
acupuncture added to their existing medical regimen
(pharmacologic and/or psychosocial) or no previous
therapy at all, and will be monitored for changes in
their outcomes (i.e. inattention, hyperactivity and impul-
sivity) in the short-term (3 and 6 weeks) and during a 9
week follow-up. Completion of this trial will help pro-
vide the answer to the question “Does acupuncture have
a role to play in the management of children with
ADHD?” Results of this trial will be disseminated at the
completion of the study.
This is the first acupuncture trial protocol study in
ADHD. Case studies of acupuncture effects for ADHD
already exist, especially in China, but trial protocols are
not precisely described. Our protocol will help to make
better quality acupuncture studies for ADHD. Further-
more, we tried to gather objective measurements using
CNT40. Subjective measurements, like K-ADHD-RS in
this study, are commonly used in ADHD and have ade-
quate reliability and validity. But lack of objective mea-
surements in ADHD may lead to some disputes like
parental placebo effects.
In traditional Korean medical theories, the insuffi-
ciency of yin, results in an excess of yang. The imbal-
anced condition of the whole body leads to impaired
mental symptoms like attention deficit, hyperactivity
and impulsivity. Thirteen acupuncture points have been
chosen in this context. The acupuncture points located
on the head region takes a main role for controlling the
spirit. Qi of five viscera and six bowels belong to the
head region. For balance of the whole mind and body,
Table 1 Acupuncture points selected in this protocol
Acupuncture point location
Baihui (GV20) On the head, 5 B-cun superior to the anterior hairline, on the anterior median line.
Note 1: GV20 is located in the depression 1 B-cun anterior to the midpoint of the line from the anterior hairline to the
posterior hairline.
Note 2: When the ears are folded, GV20 is located at the midpoint of the connecting line between the auricular apices.
Sishencong (EX-HN1) EX-HN1 is located four points on the vertex of the head, 1 B-cun anterior, posterior and lateral to GV20.
Hegu (LI4) On the dorsum of the hand, radial to the midpoint of the second metacarpal bone.
Quchi (LI11) On the lateral aspect of the elbow, at the midpoint of the line connecting LU5 with the lateral epicondyle of the humerus.
Note: When the elbow is fully flexed, LI11 is located in the depression on the lateral end of the cubital crease.
Sanyinjiao (SP6) On the tibial aspect of the leg, posterior to the medial border of the tivia, 3 B-cun superior to the prominence of the medial
malleolus.
Note: 1 B-cun superior to KI8.
Taichong (LR3) On the dorsum of the foot, between the first and second metatarsal bones, in the depression distal to the junction of the
bases of the two bones, over the dorsalis pedis artery.
* B-cun: Proportional bone cun. This method divides the height of the human body into 75 equal units. Using joints on the surface of the body as the primary
landmarks, the length and width of every body part is measured by such proportions.
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acupuncture points in the head region are essential.
Baihui (GV20), Sishencong (EX-HN1) are representative
points for the head region. Quchi (LI11) takes a role in
the elimination of excessive yang and Sanyinjiao (SP6)
supplements insufficient yin. It yields a better mental
balance. Hegu (LI4), Taichong (LR3) assists in harmo-
nious circulating qi and blood.
One limitation of this study involves the waitlist for
the controlled group. Many researchers commonly pre-
fer placebo controlled designs to the waitlist ones in
randomised control trials. Placebo effects of acupuncture
were actively studied in many articles and sham acu-
puncture is a representative method for an acupuncture
placebo tool. But there is a lack of consensus on the
most valid approach to establishing an acupuncture pla-
cebo. So, important aspects of the placebo acupuncture
control need to be considered. “Inert” is the main topic
in placebo acupuncture control. Placebo acupuncture
strategies mainly consist of superficial (or minimal)
insertion, non-acupuncture insertion points insertion,
and sham acupuncture. But each approach has some
defects. First, a superficial (or minimal) insertion is not
a real placebo method because it induces peripheral sen-
sory stimulation. It does not seem possible to insert acu-
puncture needles without any sensory stimulation
[64,65]. In fact, even a very mild form of placebo
acupuncture seems to exert an effect [66]. Second, non-
acupuncture insertion points may not be inert. Needling
in the areas around the traditional acupuncture points
may be equally efficient [66]. Acupuncture areas or
zones are understood to be like acupuncture points in
the current ongoing discussion. Third, some articles
have suggested that sham acupuncture may not be inert
[67,68]. Re-examination of acupuncture trials is needed,
to ascertain whether a sham that was assumed to be
inert was in fact not inert [67]. In this context, a placebo
acupuncture, as a control intervention, is not adequate
enough to observe acupuncture effects. Although waitlist
is an imperfect control method as well, we used it to
observe definite acupuncture effects in ADHD.
Not separating assessor from randomization is an
additional limitation. Every measurement was assessed
by the person who conducted the screening phase, so as
not to be blinded from randomization. Although we
tried to maintain an objective standpoint, we could not
exclude observer bias, which all researchers brought to
their work and which helped to determine their method
of research and their observations. To minimize this
bias, we involved objective ADHD measurement tools,
like CNT40 and FAIR.
Finally, a paper case record form (CRF) was used in this
study. These days, electronic case record form (e-CRF)
system, like the Clinical Data Interchange Standards
Consortium (CDISC) e-CRF, is become preferred because
of its improved quality and efficiency in trial study. In
July 2010, the Korea CDISC Coordination Committee
(K3C) started making standard e-CRF forms, but we used
paper CRF instead, due to insufficient e-CRF infrastruc-
ture. Paper CRF may lead to data loss and input errors.
The Kyung-Hee Korean Medical Center Institutional
Review Board strictly supervised data storage and man-
agement. We also reexamined the inputted data.
Subjective measurements, like K-ADHD-RS, are
commonly used in ADHD, and have the best evidence.
Although these measurements have adequate reliability
and validity, lack of objective assessment in ADHD
may lead to some disputes, like parental placebo
effects. More objective measurements, like the pre-
sently used CNT40, have to be validated in ADHD
trials. Furthermore, as an evidence-based treatment in
ADHD, acupuncture has little evidences compared
with conventional pharmacological or psychosocial
treatment. This study will give some evidence for the
effectiveness of acupuncture as an add-on treatment in
treating children with ADHD.
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